Detlev Ganten Skolkovo biomedical technologies opportunities and challenges

779 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
779
On SlideShare
0
From Embeds
0
Number of Embeds
23
Actions
Shares
0
Downloads
14
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Detlev Ganten Skolkovo biomedical technologies opportunities and challenges

  1. 1. U N I V E R S I T Ä T S M E D I Z I N B E R L I N Prof. Dr. Detlev Ganten, February 2, 2011 [email_address] BioMedical technologies at Skolkovo: Opportunities and Challenges.
  2. 2. <ul><li>The German Research System: 1991 – 2011 </li></ul><ul><li>The Excellence Initiative of the Federal Government and the Länder of Germany </li></ul><ul><li>Interdisciplinarity, priority areas in research, new institutions, new governance, education, quality control </li></ul><ul><li>The Future of medicine </li></ul><ul><li>The Role of Skolkovo </li></ul><ul><li>The World Health Summits 2009, 2010, 2011 </li></ul>
  3. 4. Science for Higher Education 19. November 2010 R&D expenditure in billions of Euro (2007 data) Source: BUFI 2010 EN
  4. 5. Excellence Initiative <ul><li>new focus on universities to enable them to: </li></ul><ul><ul><li>develop internationally visible and internationally competitive research priorities </li></ul></ul><ul><ul><li>become more attractive for top scientists and students from abroad </li></ul></ul><ul><ul><li>strengthen cooperation with non-university research institutions and industry </li></ul></ul><ul><li>shift in funding philosophy: </li></ul><ul><ul><li>focus on those institutions that already have high quality research to enable them to excel internationally </li></ul></ul><ul><ul><li>THREE LINES OF FUNDING: Graduate Schools, Research Clusters, </li></ul></ul><ul><ul><li>Governance. </li></ul></ul>Science for Higher Education 19. November 2010
  5. 6. Awards per scientific discipline per funding line 1st round Science for Higher Education 19. November 2010 Source: DFG 2010
  6. 7. <ul><li>Immanuel Kant ( 1724 – 1804) was an 18th-century German philosopher . </li></ul><ul><li>Kant was the last influential philosopher of modern Europe in the classic sequence of the theory of knowledge during the Enlightenment beginning with thinkers John Locke , George Berkeley , and David Hume </li></ul>What can we know? What shall we do? What can we hope for?
  7. 9. 300 Mio 300 Mio 100 Mio about 2 billion people are treated according to scientific standards. about 5 billion people are badly treated or not taken care of at all. 100 Mio
  8. 10. Evolutionary Medicine: our biologigal history goes back to the origins of life and works on old patents
  9. 11. Our civilisation is new, changes are fast: <ul><li>The Mismatch results in Diseases of Civilisation </li></ul><ul><li>„… THE </li></ul><ul><li>GAP…“ </li></ul><ul><li>Our Biology is very old and Evolution is slow: </li></ul>
  10. 12. <ul><li>Nutrition, Hunger </li></ul><ul><li>ORIGINALLY </li></ul><ul><li>good food utilisation, evolutionary advantage (The Survivors!) </li></ul><ul><li>TODAY </li></ul><ul><li>overweight, Diabetes, metabolic syndrome, cardiovascular diseases </li></ul>
  11. 13. 1 Compound Annual Growth Rate (CAGR) Inpatient care SOURCE: OECD 4.0 17.5 2.2 3.2 6.1 10.9 3.2 25.3 3.8 3.0 4.4 2 8 8 10 10 13 14 34 51 80 Ancillary services Day care Primary prevention Investments in medical facilities Pharmaceutical goods Outpatient care Therapeutic appliances Home health care Health administra-tion and insurance Total health care expenditure Health care spend EUR billions, 2006 Annual growth rate* Percent, 1970 - 2006 In Germany, patient care and pharmaceuticals are among the biggest health care expenditures Expenditures for primary care have been growing slower than all other expenditures Total = 230 bn.
  12. 14. <ul><li>The German Research System: 1991 – 2011 </li></ul><ul><li>The Excellence Initiative of the Federal Government and the Länder of Germany </li></ul><ul><li>Interdisciplinarity, priority areas in research, new institutions, new governance, education, quality control </li></ul><ul><li>The Future of medicine </li></ul><ul><li>The Role of Skolkovo </li></ul><ul><li>The World Health Summits 2009, 2010, 2011 </li></ul>
  13. 15. Genotype Personalised Medizine Clinical Systems Biology Bioinformatics Sequencing, Analysis Phenotype Health – Disease Cardiovascular - Neuro - Cancer micro RNA, RNAi Drugs Biologicals aaa DNA (Genome: 20.000 Genes) RNA Proteins (Proteome) Metabolites (Metabolome) Cellular Biology Organs ( Microbiome)
  14. 16. eMonitoring -Networking Sensors Analysis ? TeleMedicine – IT - for your personal Health Blut- zucker Blutdruck EKG Ther- mome- ter
  15. 17. Telemedical Center of the Charit é – Global Service Med. Service LH nein Cardiology Traumatology Internal Medicine Toxicol. & others … Anesthesia/Ints. Care Ships, Yachts, Oil Plat. Home Care Private Flights Telemedical Call Center Emergency Unit Charité Foreign Hospitals: Moscow, Shanghai Ger. Foreign Office, Ger. Embassies Intern. Companies
  16. 18. Architecture of the PfH- communication system Winkler S, Koehler F. Int J Cardiol 2010; in review. Patient Medical Partners TMC-physician Ambulance Hospital phys. GP Cardiologist Electronic Patient File Transmission paths for health data Transmission Transmission via Bluetooth Blood pressure ECG + SpO 2 Aktivity Weight Transmission via mobile phone Notification Treatmemt Control Communication paths in normal cases Communication paths in case of emergency Home emergency call IMMEDIATE REACTION Notification
  17. 19. Telemedicine helps you to feel safe, even when you are on a lonely trip to Siberia All the best to you and your family.
  18. 20. Berlin-Buch Adlershof BOSCH HU & FU GHC Global Health Care
  19. 21.
  20. 22.
  21. 23. <ul><li>The German Research System: 1991 – 2011 </li></ul><ul><li>The Excellence Initiative of the Federal Government and the Länder of Germany </li></ul><ul><li>Interdisciplinarity, priority areas in research, new institutions, new governance, education, quality control </li></ul><ul><li>The Future of medicine </li></ul><ul><li>The Role of Skolkovo </li></ul><ul><li>The World Health Summits 2009, 2010, 2011 </li></ul>
  22. 24. 300 Mio 300 Mio 100 Mio about 2 billion people are treated according to scientific standards. about 5 billion people are badly treated or not taken care of at all. 100 Mio
  23. 27. The G 8 GROUP - G 20
  24. 28. 1 Dec Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan World Health Summit serves as an annual conference of the M8
  25. 29. U N I V E R S I T Ä T S M E D I Z I N B E R L I N Prof. Dr. Detlev Ganten , February 2, 2011 [email_address] BioMedical technologies at Skolkovo: Opportunities and Challenges. THANK YOU !

×